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Abstract The microbiota of the lower female genital
tract was evaluated from vaginal swabs obtained from
623 healthy pregnant women at gestation periods of 35–
40 weeks. Isolated and identiﬁed microorganisms were
expressed as percentages of total samples. As expected,
lactobacilli made up the dominant vaginal microbiota
(70%). Enterobacteriaceae, mainly Escherichia coli,
Klebsiella spp. and Proteus, were present in 38% of the
samples, which might reﬂect the possible contamination
of vaginal tract with rectal microorganisms. Candida
albicans was present in 10% of healthy pregnant woman
assayed. Streptoccocci (Streptococcus sp. and Entero-
coccus faecalis with 3% and 4%, respectively) and other
gram-positive cocci (Staphylococcus sp., 5%), along with
other microorgansisms such as Gardnerella vaginalis
(5%) and Pseudomonas aeruginosa (2%) may represent a
potential infection risk. Streptococcus agalactiae (group
B streptococci b-hemolytic, GBS) was detected in 7% of
the samples. GBS infection is a leading cause of neonatal
morbidity and mortality in the developed world. Fur-
thermore, GBS was often co-isolated with C. albicans
(54.5%) in the samples. A complete and detailed eval-
uation of the vaginal biota swab, with particular atten-
tion to the presence of potential pathogens such as GBS,
is a preventive strategy that can provide useful infor-
mation to obstetricians and gynecologist in managing
the last days of pregnancy and delivery.
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Introduction
The microbiota of the lower female genital tract is a
dynamic, complex example of microbial colonization,
the regulation of which is not fully understood. Much of
what we know about the bacterial composition of the
female genital tract is derived from qualitative, descrip-
tive studies. Such studies are weakened by intrinsic
technical limitations. Often, even the usefulness of
qualitative data is negatively aﬀected by inappropriate
or suboptimal methods of data collection, failure to use
appropriate transport systems or enriched media, or a
lack of stringent anaerobic techniques in the processing
and culture of specimens. Isolation techniques used be-
fore the 1970s resulted in an underestimation of the
importance of anaerobic bacteria as major constituents
of the normal microbiota of the female genital tract [12].
When a very simple microbiota exists, as it does in
young adolescents, lactobacilli are usually dominant,
and when only a single isolate is recovered, it is usually a
Lactobacillus species. The most common Lactobacilllus
species include L. acidophilus and L. fermentum; less
common are L. plantarum, L. brevis, L. jensenii, L. casei,
L. delbrueckii, and L. salivarius. More than one species
may be present in an individual. Sexual activity, tampon
use, childbirth, and various other occurrences in the
reproductive life of women are associated with an in-
creasing complexity of the microbiota. Streptococcus
agalactiae (group B streptococci b-hemolytic, GBS) are
commonly found among the microbiota of the pharynx,
gastrointestinal tract, and vagina. Historically, GBS
were considered a cause of bovine mastitis (in 1887).
Although known in veterinary medicine, GBS were
virtually ignored as human pathogen until the late
1930s. In 1935, Lanceﬁeld and Hare identiﬁed GBS
in vaginal cultures from asymptomatic postpartum
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women. In 1938, three cases of fatal puerperal sepsis
were described; this was the ﬁrst report of GBS as a
human pathogen. In the 1960s, some reports noted the
role of GBS in perinatal infections [1]. Subsequently, an
increasing number of studies in the obstetric and pedi-
atric literature documented a growing concern with
neonatal sepsis and/or meningitis due to GBS. GBS re-
main the predominant cause of invasive bacterial disease
in the neonatal period. Studies in the USA demonstrated
a risk of 1–2 cases per 1,000 live births. Incidence rates
for diﬀerent European countries vary between 0.24 and
1.26 per 1,000 live births [19]. Due to modern neonatal
intensive care, fatality rates have declined during the last
few decades but still range from 4 to 6% [17]. A con-
siderable number of children, especially among menin-
gitis survivors, suﬀer long-term sequelae. Prematurity is
one of the risk factors for GBS disease, and morbidity
and mortality rates are higher among these patients.
Therefore, with the overall improvements in survival
rates, the clinical community has turned its attention to
research on disease prevention [4]. The consensus
guidelines have urged institutions and caregivers to
adopt a prevention strategy for GBS disease and
recommended the following approaches: (1) a screening-
based strategy, and (2) a risk-based strategy, as dis-
cussed by Schuchat [18] (Table 1). Preventive strategies
based only on maternal risk factors would prevent less
than half the cases of neonatal diseases [8]. Therefore
main goal of this study was to assess the beneﬁts of a
complete and detailed evaluation of the vaginal biota
swab, with particular attention to the presence of
potential pathogens such as GBS.
Materials and methods
A total of 623 vaginal swabs from 623 healthy pregnant woman
were collected from January 1998 to December 2000. Samples were
taken by gynecologists and obstetricians in their consulting room.
Vaginal swabs were transported to the laboratory on Amies me-
dium (IASA, Rubı´, Spain). Patient ages ranged from 18 to 45 years
(mean=29 years), and with a gestation period of 35–40 weeks
(mean=38 weeks). Microbial colonies were obtained from 603
samples (96.8%); 20 samples (3.2%) yielded no growth.
Samples were inoculated on tryptone soy agar (Merck,
Darmstadt, Germany), blood agar (Merck, Darmstadt, Germany)
and Todd-Hewitt broth with 25 mg gentamicin/l and 25 mg nali-
dixic acid/l (Oxoid, Hampshire, England). Cultures were incubated
at 37 C for 4 days. Axenic cultures obtained were identiﬁed fol-
lowing standard methods [2,16]. Serological typing of streptococci
was carried out using an agglutination test (Menarini Diagnostics).
Results and discussion
A list of the vaginal aerobic (and/or anaerobic faculta-
tive) microbiota in 623 healthy pregnant women is
shown in Table 2 as the frequency of positive results
with respect to the total number of samples. The results
are compared with those obtained previously [11]. The
vagina of the adult female generally is weakly acidic and
contains signiﬁcant amounts of L. acidophilus and
Table 1. Strategies for the prevention of early onset group B streptococcal (GBS) diseases [18]
Approach Prenatal component Intrapartum component
Screening-based
strategy
Obtain vaginal and rectal swab specimens at 35-37
weeks gestation and inoculate in selective broth
media; assess history of previous infant(s)
with GBS disease and presence of GBS
bacteriuria during current pregnancy
Oﬀer intrapartum penicillin (ampicillin, clindamycin
or erythromycin) to women with GBS identiﬁed
on prenatal cultures, previous infant(s) with GBS
disease, GBS bacteriuria during this pregnancy
Risk-based strategy Determine history of previous infant(s) with GBS
disease and presence of GBS bacteriuria during
current pregnancy
Oﬀer intrapartum penicillin (ampicillin, clindamycin or
erythromycin) to women with previous infant(s) with
GBS disease, GBS bacteriuria during this pregnancy
Table 2. A comparison of the
prevalence of the aerobic (and/
or facultative anaerobic) iso-
lates in vaginal microbiota stu-
dies. Percentage indicates the
frequency of positive results
with respect to the total number
(603) of positive samples
Aerobic (and/or anaerobic
facultative) isolates
Number
of isolatesa
Prevalence in
vaginal biota (%)a
Prevalence in
vaginal biota (%)b
Lactobacilli 436 70 60
Diphteroids 60 10 40
Staphylococcus aureus or sp. 31 5 2
Staphylococcus epidermidis 44 7 50
Streptococcus agalactiae 44 7 15
Sreptococcus sp. (nonhemolytic) 19 3 20
Enterococcus faecalis 25 4 28
Escherichia coli 168 27 18
Klebsiella spp./Enterobacter spp. 6 1 10
Proteus spp. 63 10 5
Pseudomonas sp. 12 2 0.1
Gardnerella vaginalis 30 5 –
Candida albicans 63 10 –
aThis work
bResults of [11]
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L. fermentus. Lactobacilli seem to control the bacterial
microbiota in this microhabitat, primarily by the pro-
duction of acids that decrease pH, which inhibits the
growth of microorganisms such as G. vaginalis, Pepto-
streptococcus sp. and Bacteroides sp. It has been sug-
gested that lactobacilli form a continuous bioﬁlm which
blocks the attachment of other bacteria, including
pathogenic ones [14]. Special attention has been given to
the idea that hydrogen peroxide production is a mech-
anism of bacterial antagonism of Lactobacillus species.
Hillier et al. [9] showed a signiﬁcant correlation between
the absence of hydrogen-peroxide-producing lactobacilli
and vaginal colonization by G. vaginalis, Bacteroides sp.,
Peptostreptococcus sp. and Mycoplasma hominis.
Within colonized tissues, what constitutes a pathogen
is dependent not only on the type of ‘‘oﬀending’’ mi-
croorganism and its intrinsic virulence but also on the
species complexity of the microbiota– that is, the relative
dominance, in numbers, in individual asymptomatic
patients. The mere presence of a potentially pathogenic
species does not necessarily cause disease as deﬁned in
terms of symptoms. For example, Candida albicans may
be present without the typical symptoms of yeast vagi-
nitis (see Table 2; C. albicans is present in 10% of
healthy pregnant woman included in the assays). Yeast
carriage varies among populations and increases both
after puberty and during pregnancy, which suggests an
important role of the host physiology [12]. Estrogen
promotes the growth of bacteria in the genital tract [7].
The prevalence of both Lactobacillus species and yeast in
diﬀerent populations indicates that the times of the
highest prevalence of Lactobacillus species (during the
reproductive years and, especially, during pregnancy)
coincide with those of the highest prevalence of Candida
species. Enterobacteriaceae, mainly Escherichia coli,
Klebsiella spp. and Proteus spp., were present in 38% of
the samples; this result may reﬂect possible contamina-
tion of the vaginal tract by rectal microorganisms. The
colonization with Enterobacteriaceae species is also a
predisposing factor for urinary tract infection in women
[15]. Anaerobic microbiota were also detected (Bacte-
roides spp. was present in 12% of the samples). Strep-
tococci, other gram-positive cocci, and others potential
pathogens, such as G. vaginalis, P. aeruginosa and
C. albicans, indicate a potential risk of infection to the
mother.
Anywhere from 5% to 35% of women are asymp-
tomatic carriers of GBS in the genital tract [3, 10, 20].
In our study, Streptococcus agalactiae (GBS) was
detected in 7% of the samples (see Table 2). Note that
there are signiﬁcant geographic variation in the per-
centage of women colonized with GBS [20]. Up to
60% of the colonized women will carry the organism
intermittently. Indeed, colonization of the vagina may
actually reﬂect also a contamination from the rectum,
with the gastrointestinal tract being the principal res-
ervoir of this organism [6]. At birth, one in two infants
who are born to colonized mothers will themselves be
colonized on the skin or mucosal surfaces. Approxi-
mately 98% of colonized newborns have no symp-
toms, but 1–2% develop early-onset disease, in which
sepsis, pneumonia, or meningitis occur during the
ﬁrst week of life. The vast majority of early-onset
infections are evident within hours of birth [18]. GBS
are frequently co-isolated with C. albicans; 54.5% of
samples positive for GBS were also positive to
C. albicans. This results is in accordance with those of
other studies [5,13].
In 223 of 623 women examined (36%), potentially
pathogenic microorganisms were isolated that could
disrupt the normal progression of the last weeks of
pregnancy or even delivery. Thus, we conclude that,
during the last weeks of pregnancy, the identiﬁcation of
microbial populations present in vaginal swabs can
provide detailed information about the vaginal micro-
biota at this time. This may help to reduce, at low cost,
any possible infectious disease problems at the neonatal,
delivery, and postpartum stages.
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